Cellvie Is A Biotechnology Company Based In Za Richswitzerlandspecializing In Therapeutic Mitochondria Transplantationtmt This Innovative Approach Aims To Enhance Cellular Energy Metabolism By Transplanting Mitochondria Into Compromised Cellsthe Technologydeveloped By Drjames Mccully At Harvard Medical Schoolfocuses On Restoring Energy Metabolism Through Proprietary Methods That Allow Mitochondria To Integrate With Existing Cellular Networks The Initial Applications Of Tmt Target Ischemia Reperfusion Injuriesparticularly In Heart Attacks And Solid Organ Transplantssuch As Kidney Transplantscellvie Is Also Exploring The Use Of Tmt In Gene Therapy Deliverythe Company Is Open To Collaboration Opportunities For Co Development And Licensing Agreementsworking Closely With Clinical Key Opinion Leaders To Advance Its Therapeutic Approachesled By Ceo Alexander Schuellercellvie Emphasizes Innovation And Collaboration To Bring Its Technology From The Lab To Clinical Practice
